Neogen (NEOG) Liabilities and Shareholders Equity (2010 - 2026)
Neogen (NEOG) recorded quarterly Liabilities and Shareholders Equity of $3.4 billion in Q1 2026, little changed quarter-over-quarter from $3.4 billion in Q4 2025, and up 1917.42% on a YoY basis from $166.5 million in Q1 2025.
Neogen (NEOG) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Neogen's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $3.4 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 1917.42% year-over-year to $3.4 billion; the TTM figure through Feb 2026 stood at $13.5 billion (up 9.67% YoY), while the FY2025 annual figure was $3.4 billion, down 24.29% from the prior year.
- Liabilities and Shareholders Equity was $3.4 billion for Q1 2026 at Neogen, roughly flat from $3.4 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $4.6 billion in Q4 2023 to a low of $166.5 million in Q1 2025.
- Historically, Liabilities and Shareholders Equity has averaged $3.3 billion across 5 years, with a median of $3.6 billion in 2024.
- The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity plunged 96.37% in 2025, then soared 1917.42% in 2026.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $4.6 billion in 2022, then climbed by 0.86% to $4.6 billion in 2023, then fell by 22.31% to $3.6 billion in 2024, then slipped by 6.03% to $3.4 billion in 2025, then dropped by 0.03% to $3.4 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $3.4 billion (Q1 2026), $3.4 billion (Q4 2025), and $3.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | 3.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 3.36 Bn |
| Nov 30, 2025 | 3.36 Bn |
| Aug 31, 2025 | 3.38 Bn |
| May 31, 2025 | 3.44 Bn |
| Feb 28, 2025 | 166.50 Mn |
| Nov 30, 2024 | 3.58 Bn |
| Aug 31, 2024 | 4.06 Bn |
| May 31, 2024 | 4.55 Bn |
| Feb 29, 2024 | 4.58 Bn |
| Nov 30, 2023 | 4.60 Bn |
| Aug 31, 2023 | 4.56 Bn |
| May 31, 2023 | 4.55 Bn |
| Feb 28, 2023 | 4.51 Bn |
| Nov 30, 2022 | 4.56 Bn |
| Aug 31, 2022 | 977.41 Mn |
| May 31, 2022 | 992.93 Mn |
| Feb 28, 2022 | 981.21 Mn |
| Nov 30, 2021 | 967.93 Mn |
| Aug 31, 2021 | 932.11 Mn |
| May 31, 2021 | 920.19 Mn |